Tectonic Therapeutic | AVRO - Assets


Tectonic Therapeutic reported $277M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Alnylam Pharmaceuticals USD 4.85B 285.64M Sep/2025
Celltrion KRW 21.08T 530.63B Sep/2025
Cspc Pharmaceutical CNY 46B 1.61B Jun/2025
Dianthus Therapeutics USD 577.44M 251.37M Sep/2025
Divis Laboratories Ltd INR 181.51B 12.19B Sep/2025
Gilead Sciences USD 58.53B 2.81B Sep/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
Kangmei Pharma CNY 13.68B 38.19M Sep/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
MacroGenics USD 270.76M 25.34M Sep/2025
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 66.4M 1.06M Jun/2025
Neuren Pharmaceuticals AUD 331.25M 78.46M Jun/2025
Organigram Holdings CAD 562.21M 2.4M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Pharma Mar EUR 341.66M 6.59M Sep/2025
Qiagen NV USD 6.55B 729.74M Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Sarepta Therapeutics USD 3.49B 186.38M Sep/2025
Sartorius EUR 9.61B 413.4M Sep/2025
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Takeda JPY 15.41T 938.47B Dec/2025
Tilray USD 2.07B 1.33B Mar/2025
Zz Pientze Pharmaceu CNY 17.48B 1.23B Sep/2025